We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

50 hedge funds and large institutions have $45.9M invested in EnteroMedics Inc. in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

666% more call options, than puts

Call options by funds: $1.33M | Put options by funds: $174K

100% more capital invested

Capital invested by funds: $23M → $45.9M (+$22.9M)

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

19% more funds holding

Funds holding: 4250 (+8)

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

Holders
50
Holders Change
+8
Holders Change %
+19.05%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
11
Reduced
10
Closed
9
Calls
$1.33M
Puts
$174K
Net Calls
+$1.16M
Net Calls Change
+$1.15M

ETRM Hedge Fund Activity: Q4 2013 in Review

50 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q4 2013, worth a combined $45.9M — up 100% from $23M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ETRM positions and 9 closed out — a net gain of 8 holders — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Royce & Associates, adding an estimated $1.92M. The largest seller was Wells Fargo, cutting an estimated $625K.

  • 50 institutional investors held EnteroMedics Inc. (ETRM) as of Q4 2013, up from 42 in Q3 2013.
  • Funds reported $45.9M of EnteroMedics Inc. stock for Q4 2013, up 100% quarter-over-quarter.
  • 17 funds opened new EnteroMedics Inc. positions in Q4 2013 and 9 closed out, a net change of +8 holders.
  • The largest EnteroMedics Inc. buyer in Q4 2013 was Royce & Associates, an estimated $1.92M added.
  • The largest EnteroMedics Inc. seller in Q4 2013 was Wells Fargo, an estimated $625K sold.

Based on aggregated 13F filings for Q4 2013.